Novartis China
Aboutthe company
Market position and key achievements
Novartis China
Brief Description
Novartis China — a division of the Swiss pharmaceutical company Novartis, one of the world's leaders in developing innovative medicines. In China, the company actively invests in research, clinical programs, and digital health solutions, with particular focus on oncology, immunology, and rare diseases.
Main Products / Services and Key Markets
- Innovative prescription drugs
- Therapies in oncology, immunology, ophthalmology
- Clinical research, scientific partnerships, and digital health
- Key markets — hospitals, clinical centers, pharmaceutical networks in China
Year of Establishment, Scale, Presence
- Novartis founded in 1996 (legacy of Sandoz and Ciba-Geigy)
- In China — R&D centers, offices, medical teams, partnerships with universities
- One of the company's most important strategic markets
What Makes Their Exhibition Hall / Activities Interesting
- Showcase of innovative drug platforms and therapeutic lines
- Demonstration of scientific processes: R&D, clinical research, safety
- Insights into digital solutions in medicine and big data applications
- Understanding of Novartis's strategy as a science-driven pharmaceutical company
Visitprogramme
What the visit includes
Visit Program
09:00–10:00 Visit to the Novartis exhibition hall — innovation portfolio, scientific developments, medical technologies
10:00–11:30 Thematic presentation: Novartis — R&D and Innovation — research, clinical programs, new therapeutic approaches
Note: The presented program is a brief introductory description.
For more detailed content, please send us a message, and we will send you an extended version of the program.
Ready to visitNovartis China?
Send a request and we'll arrange an exclusive visit tailored to your needs